This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cell (MCF7)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Caput luminal fluid
Cauda epithelial cell
Cauda luminal fluid
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Epidermal melanocyte (HEMa-LP)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Malignant melanoma cell (A375)
Mammary gland cells (NMuMG)
Mast cell (HMC-1)
Multiple myeloma cells (U266)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Seminal plasma
Serum
T cell (Jurkat)
By sample status
24 hr culture
72 hr culture
Cisplatin-resistant
Healthy_timepoint2
High density
Hypoxic condition (24 hr)
Mild hand, foot, and mouth disease
Normal
Normal_Agilent
Omeprazole-treated
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Survived under long-term hypoxia
Type 1 diabetes
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-494-3p
MIMAT0002816
0.0e+0
3.6e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
4.1e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
2.4e-3
4.4e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
1.0e-4
4.1e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
3.7e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
2.2e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
3.8e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
2.2e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
0.0e+0
5.1e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
1.1e-3
1.1e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000018_2
89
/
0
/
89
hsa-miR-494-3p
MIMAT0002816
1.7e-3
1.7e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000018_2
89
/
0
/
89
<
[2]